A combination of an NMDA-antagonist and acetylcholine esterase inhibitors for the treatment of Alzheimer's disease

摘要

Disclosed is a use of a composition comprising: (a) an effective amount of one or more acetylcholinesterase (AChE) inhibitor (s) or a pharmaceutically acceptable salt thereof and (b) an effective amount of one or more NMDA-antagonist (s) or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of mild cognitive impairment or dementia in connection with moderate to severe Alzheimer's.